Chimeric antibody targeting unique epitope on onco-mucin16 reduces tumor burden in pancreatic and lung malignancies
Abstract Aberrantly expressed onco-mucin 16 (MUC16) and its post-cleavage generated surface tethered carboxy-terminal (MUC16-Cter) domain are strongly associated with poor prognosis and lethality of pancreatic (PC) and non-small cell lung cancer (NSCLC). To date, most anti-MUC16 antibodies are direc...
প্রধান লেখক: | , , , , , , , , , , , , , , , , , , , , , |
---|---|
বিন্যাস: | প্রবন্ধ |
ভাষা: | English |
প্রকাশিত: |
Nature Portfolio
2023-08-01
|
মালা: | npj Precision Oncology |
অনলাইন ব্যবহার করুন: | https://doi.org/10.1038/s41698-023-00423-7 |